Two Sigma Advisers
LNAI

Two Sigma Advisers’s Lunai Bioworks LNAI Stock Holding History

Two Sigma Advisers’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-415
Closed -$18.8K – 2542
2023
Q2 		$18.8K Sell
415
-290
-41% -$22.3K ﹤0.01% 2326
2023
Q1 		$51.6K Sell
705
-271
-28% -$23.8K ﹤0.01% 2446
2022
Q4 		$80.4K Sell
976
-414
-30% -$55.6K ﹤0.01% 2319
2022
Q3 		$201K Buy
1,390
+912
+191% +$166K ﹤0.01% 2197
2022
Q2 		$74K Buy
+478
New +$219K ﹤0.01% 2429

Other funds holding LNAI

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Two Sigma Advisers's LNAI Position: Q3 2023 in Review

Two Sigma Advisers sold out of Lunai Bioworks (LNAI) in Q3 2023, closing a stake of 415 shares — an estimated $18.8K sold.

Two Sigma Advisers first reported a position in LNAI in Q2 2022 and held it in 5 quarters. The position peaked at $201K in Q3 2022. 21 funds tracked by Wall St. Rank hold LNAI as of Q3 2023.

  • Two Sigma Advisers reported no remaining Lunai Bioworks position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 415 Lunai Bioworks shares in Q3 2023, an estimated $18.8K.
  • Two Sigma Advisers first reported a position in Lunai Bioworks in Q2 2022 and held it in 5 quarters.
  • Two Sigma Advisers's Lunai Bioworks position peaked at $201K in Q3 2022.
  • 21 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2023.

Based on Two Sigma Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.